{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,24]],"date-time":"2026-07-24T17:56:43Z","timestamp":1784915803700,"version":"3.55.0"},"reference-count":75,"publisher":"Bentham Science Publishers Ltd.","issue":"16","content-domain":{"domain":["eurekaselect.com"],"crossmark-restriction":true},"short-container-title":["CCHTS"],"published-print":{"date-parts":[[2024,10]]},"abstract":"<jats:sec>\n<jats:title>Background:<\/jats:title>\n<jats:p>Poorly differentiated thyroid cancer (PDTC) is a special type of thyroid\ncancer that threatens the life of the patients. Unfortunately, there are no effective treatments for\nPDTC right now, so it is urgent to search for new efficacious drugs. This experiment was designed\nto elucidate the effects of selenomethionine (SeMet) on PDTC in vitro and vivo.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Methods:<\/jats:title>\n<jats:p>A xenograft animal model was used to assay the volume and weight of PDTC. LncRNA\nNOMMMUT014201 expression was detected by fluorescence in situ hybridization and Real-time\nquantitative PCR (qRT-PCR). In vitro experiments were carried on in WRO cells. The Cell Counting\nKit-8 assay was performed to test the effect of SeMet on the proliferation of cells. And the migration\nand invasion of WRO cells by the wound-healing assay, Transwell migration and invasion\nassays. The cell apoptosis was measured by flow cytometry. In addition, genes related to proliferation,\nmigration, invasion and apoptosis were detected through qRT-PCR and Western Blot.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Results:<\/jats:title>\n<jats:p>SeMet inhibited the proliferation, migration and invasion and promoted the apoptosis of\nWRO cells in a dose-dependent manner. Then vivo, SeMet significantly suppressed the volume\nand weight of PDTC. And SeMet downregulated the expressions of Ki67, PCNA, MMP2,\nMMP9 and BCL2, but upregulated that of BAX and Cleaved-Caspase 3. Moreover, SeMet upregulated\nthe level of LncRNA NOMMMUT014201 both vivo and in vitro. In addition, repression\nof LncRNA NOMMMUT014201 removed the inhibition effect of SeMet on WRO cell\ngrowth significantly (p&lt;0.05). Further investigation showed that LncRNA NOMMMUT014201\ndownregulated the expression of miR-6963-5p in PDTC cells, but miR-6963-5p inhibited the\nlevel of Srprb. In addition, sh-LncRNA NOMMMUT014201 enhanced the proliferation, migration\nand invasion but inhibited the apoptosis of WRO cells. However, inhibited miR-6963-5p or\noverexpressed Srprb relieved the effects of sh-LncRNA NOMMMUT014201on WRO cells.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Conclusion:<\/jats:title>\n<jats:p>Collectively, SeMet inhibits the growth of PDTC in a dose-dependent manner\nthrough LncRNA NONMMUT014201\/miR-6963-5p\/Srprb signal pathway, thus suggesting that\nSeMet might be a potential drug for PDTC treatment.<\/jats:p>\n<\/jats:sec>","DOI":"10.2174\/0113862073286006231228070738","type":"journal-article","created":{"date-parts":[[2024,1,4]],"date-time":"2024-01-04T04:42:06Z","timestamp":1704343326000},"page":"2419-2432","update-policy":"https:\/\/doi.org\/10.2174\/bsp_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Selenomethionine Suppress the Progression of Poorly Differentiated Thyroid\nCancer <i>via<\/i> LncRNA NONMMUT014201\/miR-6963-5p\/Srprb Pathway"],"prefix":"10.2174","volume":"27","author":[{"given":"Rongfang","family":"Pan","sequence":"first","affiliation":[{"name":"Department of Endocrinology and Metabology, Shandong Provincial Qianfoshan Hospital, Shandong University,\nJi-nan 250014, China"},{"name":"Department of Nutrition, The Affiliated Hospital of Qingdao University, Qingdao 266000,\nShandong, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junyu","family":"Zhao","sequence":"additional","affiliation":[{"name":"Department of Endocrinology and Metabology, The First Affiliated Hospital of Shandong First Medical\nUniversity &amp; Shandong Provincial Qianfoshan Hospital, Shandong Key Laboratory of Rheumatic Disease and\nTranslational Medicine, Shandong Institute of Nephrology, Jinan, 250014, Shandong, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinming","family":"Yao","sequence":"additional","affiliation":[{"name":"Department of Endocrinology and Metabology, The First Affiliated Hospital of Shandong First Medical\nUniversity &amp; Shandong Provincial Qianfoshan Hospital, Shandong Key Laboratory of Rheumatic Disease and\nTranslational Medicine, Shandong Institute of Nephrology, Jinan, 250014, Shandong, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanyan","family":"Gao","sequence":"additional","affiliation":[{"name":"Department of Endocrinology\nand Metabolism, The Affiliated Hospital of Qingdao University, Qingdao, 266000, Shandong, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lin","family":"Liao","sequence":"additional","affiliation":[{"name":"Department of Endocrinology and Metabology, Shandong Provincial Qianfoshan Hospital, Shandong University,\nJi-nan 250014, China"},{"name":"Department of Endocrinology and Metabology, The First Affiliated Hospital of Shandong First Medical\nUniversity &amp; Shandong Provincial Qianfoshan Hospital, Shandong Key Laboratory of Rheumatic Disease and\nTranslational Medicine, Shandong Institute of Nephrology, Jinan, 250014, Shandong, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"965","reference":[{"key":"ref=1","doi-asserted-by":"publisher","first-page":"1941","DOI":"10.1002\/ijc.31937","volume":"144","author":"Ferlay J.","year":"2019","unstructured":"Ferlay J.; Colombet M.; Soerjomataram I.; Mathers C.; Parkin D.M.; Pi\u00f1eros M.; Znaor A.; Bray F.; Estimating the global cancer incidence and mortality in 2018: GLOBOCAN sources and methods. Int J Cancer  2019,144(8),1941-1953","journal-title":"Int J Cancer"},{"key":"ref=2","doi-asserted-by":"publisher","first-page":"115","DOI":"10.3322\/caac.21338","volume":"66","author":"Chen W.","year":"2016","unstructured":"Chen W.; Zheng R.; Baade P.D.; Zhang S.; Zeng H.; Bray F.; Jemal A.; Yu X.Q.; He J.; Cancer statistics in China, 2015. CA Cancer J Clin  2016,66(2),115-132","journal-title":"CA Cancer J Clin"},{"key":"ref=3","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1089\/thy.2015.0020","volume":"26","author":"Haugen B.R.","year":"2016","unstructured":"Haugen B.R.; Alexander E.K.; Bible K.C.; Doherty G.M.; Mandel S.J.; Nikiforov Y.E.; Pacini F.; Randolph G.W.; Sawka A.M.; Schlumberger M.; Schuff K.G.; Sherman S.I.; Sosa J.A.; Steward D.L.; Tuttle R.M.; Wartofsky L.; 2015 American thyroid association management guidelines for adult patients with thyroid nodules and differentiated thyroid cancer: The american thyroid association guidelines task force on thyroid nodules and differentiated thyroid cancer. Thyroid  2016,26(1),1-133","journal-title":"Thyroid"},{"key":"ref=4","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1089\/thy.2018.0509","volume":"29","author":"Ibrahimpasic T.","year":"2019","unstructured":"Ibrahimpasic T.; Ghossein R.; Shah J.P.; Ganly I.; Poorly differentiated carcinoma of the thyroid gland: Current status and future prospects. Thyroid  2019,29(3),311-321","journal-title":"Thyroid"},{"key":"ref=5","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1111\/cen.14010","volume":"91","author":"Barczynski M.","year":"2019","unstructured":"Barczynski M.; Commentary on the study of Walczyk et al. Poorly differentiated thyroid cancer in the context of the revised 2015 american thyroid association guidelines and the updated american joint committee on cancer\/tumor-node-metastasis staging system. Clin Endocrinol  2019,91,245-246","journal-title":"Clin Endocrinol"},{"key":"ref=6","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1016\/S0140-6736(00)02490-9","volume":"356","author":"Rayman M.P.","year":"2000","unstructured":"Rayman M.P.; The importance of selenium to human health. Lancet  2000,356(9225),233-241","journal-title":"Lancet"},{"key":"ref=7","doi-asserted-by":"publisher","first-page":"1256","DOI":"10.1016\/S0140-6736(11)61452-9","volume":"379","author":"Rayman M.P.","year":"2012","unstructured":"Rayman M.P.; Selenium and human health. Lancet  2012,379(9822),1256-1268","journal-title":"Lancet"},{"key":"ref=8","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1080\/10590501.2015.1055163","volume":"33","author":"Jablonska E.","year":"2015","unstructured":"Jablonska E.; Vinceti M.; Selenium and human health: Witnessing a copernican revolution? J Environ Sci Health Part C Environ Carcinog Ecotoxicol Rev  2015,33(3),328-368","journal-title":"J Environ Sci Health Part C Environ Carcinog Ecotoxicol Rev"},{"key":"ref=9","doi-asserted-by":"publisher","first-page":"1852","DOI":"10.3390\/nu11081852","volume":"11","author":"Schomburg L.","year":"2019","unstructured":"Schomburg L.; Orho-Melander M.; Struck J.; Bergmann A.; Melander O.; Selenoprotein-P deficiency predicts cardiovascular disease and death. Nutrients  2019,11(8),1852","journal-title":"Nutrients"},{"key":"ref=10","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1007\/s10654-018-0422-8","volume":"33","author":"Vinceti M.","year":"2018","unstructured":"Vinceti M.; Filippini T.; Rothman K.J.; Selenium exposure and the risk of type 2 diabetes: A systematic review and meta-analysis. Eur J Epidemiol  2018,33(9),789-810","journal-title":"Eur J Epidemiol"},{"key":"ref=11","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1007\/s12011-018-1492-x","volume":"189","author":"Varikasuvu S.R.","year":"2019","unstructured":"Varikasuvu S.R.; Prasad V S.; Kothapalli J.; Manne M.; Brain selenium in alzheimer\u2019s disease (BRAIN SEAD Study): A systematic review and meta-analysis. Biol Trace Elem Res  2019,189(2),361-369","journal-title":"Biol Trace Elem Res"},{"key":"ref=12","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1159\/000502357","volume":"54","author":"Adani G.","year":"2020","unstructured":"Adani G.; Filippini T.; Michalke B.; Vinceti M.; Selenium and other trace elements in the etiology of parkinson\u2019s disease: A systematic review and meta-analysis of case-control studies. Neuroepidemiology  2020,54(1),1-23","journal-title":"Neuroepidemiology"},{"key":"ref=13","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/j.jtemb.2019.07.007","volume":"56","author":"Ma Y.","year":"2019","unstructured":"Ma Y.; Zhang X.; Fan D.; Xia Q.; Wang M.; Pan F.; Common trace metals in rheumatoid arthritis: A systematic review and meta-analysis. J Trace Elem Med Biol  2019,56,81-89","journal-title":"J Trace Elem Med Biol"},{"key":"ref=14","doi-asserted-by":"publisher","first-page":"699652","DOI":"10.3389\/fnut.2021.699652","volume":"8","author":"Evenson J.K.","year":"2021","unstructured":"Evenson J.K.; Sunde R.A.; Metabolism of tracer 75Se selenium from inorganic and organic selenocompounds into selenoproteins in rats, and the missing 75Se metabolites. Front Nutr  2021,8,699652","journal-title":"Front Nutr"},{"key":"ref=15","doi-asserted-by":"publisher","first-page":"5059","DOI":"10.1021\/jm060076r","volume":"49","author":"Ekins S.","year":"2006","unstructured":"Ekins S.; Balakin K.V.; Savchuk N.; Ivanenkov Y.; Insights for human ether-a-go-go-related gene potassium channel inhibition using recursive partitioning and kohonen and sammon mapping techniques. J Med Chem  2006,49(17),5059-5071","journal-title":"J Med Chem"},{"key":"ref=16","doi-asserted-by":"publisher","first-page":"1642","DOI":"10.1016\/j.bbagen.2014.10.008","volume":"1850","author":"Fernandes A.P.","year":"2015","unstructured":"Fernandes A.P.; Gandin V.; Selenium compounds as therapeutic agents in cancer. Biochim Biophys Acta, Gen Subj  2015,1850(8),1642-1660","journal-title":"Biochim Biophys Acta, Gen Subj"},{"key":"ref=17","first-page":"CD005195","volume":"1","author":"Vinceti M.","year":"2018","unstructured":"Vinceti M.; Filippini T.; Del Giovane C.; Dennert G.; Zwahlen M.; Brinkman M.; Zeegers M.P.; Horneber M.; D\u2019Amico R.; Crespi C.M.; Selenium for preventing cancer. Cochrane Database Syst Rev  2018,1(1),CD005195","journal-title":"Cochrane Database Syst Rev"},{"key":"ref=18","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/bs.acr.2017.07.001","volume":"136","author":"Vinceti M.","year":"2017","unstructured":"Vinceti M.; Filippini T.; Cilloni S.; Crespi C.M.; The epidemiology of selenium and human cancer. Adv Cancer Res  2017,136,1-48","journal-title":"Adv Cancer Res"},{"key":"ref=19","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1001\/jama.2008.864","volume":"301","author":"Lippman S.M.","year":"2009","unstructured":"Lippman S.M.; Klein E.A.; Goodman P.J.; Lucia M.S.; Thompson I.M.; Ford L.G.; Parnes H.L.; Minasian L.M.; Gaziano J.M.; Hartline J.A.; Parsons J.K.; Bearden J.D.; Crawford E.D.; Goodman G.E.; Claudio J.; Winquist E.; Cook E.D.; Karp D.D.; Walther P.; Lieber M.M.; Kristal A.R.; Darke A.K.; Arnold K.B.; Ganz P.A.; Santella R.M.; Albanes D.; Taylor P.R.; Probstfield J.L.; Jagpal T.J.; Crowley J.J.; Meyskens F.L.; Baker L.H.; Coltman C.A.; Effect of selenium and vitamin E on risk of prostate cancer and other cancers: The Selenium and Vitamin E Cancer Prevention Trial (SELECT). JAMA  2009,301(1),39-51","journal-title":"JAMA"},{"key":"ref=20","doi-asserted-by":"publisher","first-page":"2048","DOI":"10.1002\/cncr.26526","volume":"118","author":"Greenlee H.","year":"2012","unstructured":"Greenlee H.; Kwan M.L.; Kushi L.H.; Song J.; Castillo A.; Weltzien E.; Quesenberry C.P.; Caan B.J.; Antioxidant supplement use after breast cancer diagnosis and mortality in the life after cancer epidemiology (LACE) cohort. Cancer  2012,118(8),2048-2058","journal-title":"Cancer"},{"key":"ref=21","doi-asserted-by":"publisher","first-page":"730","DOI":"10.1046\/j.1464-410x.1998.00630.x","volume":"81","author":"Clark L.C.","year":"1998","unstructured":"Clark L.C.; Dalkin B.; Krongrad A.; Combs G.F.; Turnbull B.W.; Slate E.H.; Witherington R.; Herlong J.H.; Janosko E.; Carpenter D.; Borosso C.; Falk S.; Rounder J.; Decreased incidence of prostate cancer with selenium supplementation: Results of a double\u2010blind cancer prevention trial. Br J Urol  1998,81(5),730-734","journal-title":"Br J Urol"},{"key":"ref=22","doi-asserted-by":"publisher","first-page":"406","DOI":"10.3945\/ajcn.116.131672","volume":"104","author":"Hughes D.J.","year":"2016","unstructured":"Hughes D.J.; Duarte-Salles T.; Hybsier S.; Trichopoulou A.; Stepien M.; Aleksandrova K.; Overvad K.; Tj\u00f8nneland A.; Olsen A.; Affret A.; Fagherazzi G.; Boutron-Ruault M.C.; Katzke V.; Kaaks R.; Boeing H.; Bamia C.; Lagiou P.; Peppa E.; Palli D.; Krogh V.; Panico S.; Tumino R.; Sacerdote C.; Bueno-de-Mesquita H.B.; Peeters P.H.; Engeset D.; Weiderpass E.; Lasheras C.; Agudo A.; S\u00e1nchez M.J.; Navarro C.; Ardanaz E.; Dorronsoro M.; Hemmingsson O.; Wareham N.J.; Khaw K.T.; Bradbury K.E.; Cross A.J.; Gunter M.; Riboli E.; Romieu I.; Schomburg L.; Jenab M.; Prediagnostic selenium status and hepatobiliary cancer risk in the european prospective investigation into cancer and nutrition cohort. Am J Clin Nutr  2016,104(2),406-414","journal-title":"Am J Clin Nutr"},{"key":"ref=23","doi-asserted-by":"publisher","first-page":"1149","DOI":"10.1002\/ijc.29071","volume":"136","author":"Hughes D.J.","year":"2015","unstructured":"Hughes D.J.; Fedirko V.; Jenab M.; Schomburg L.; M\u00e9plan C.; Freisling H.; Bueno-de-Mesquita H.B.; Hybsier S.; Becker N.P.; Czuban M.; Tj\u00f8nneland A.; Outzen M.; Boutron-Ruault M.C.; Racine A.; Bastide N.; K\u00fchn T.; Kaaks R.; Trichopoulos D.; Trichopoulou A.; Lagiou P.; Panico S.; Peeters P.H.; Weiderpass E.; Skeie G.; Dagrun E.; Chirlaque M.D.; S\u00e1nchez M.J.; Ardanaz E.; Ljuslinder I.; Wennberg M.; Bradbury K.E.; Vineis P.; Naccarati A.; Palli D.; Boeing H.; Overvad K.; Dorronsoro M.; Jakszyn P.; Cross A.J.; Quir\u00f3s J.R.; Stepien M.; Kong S.Y.; Duarte-Salles T.; Riboli E.; Hesketh J.E.; Selenium status is associated with colorectal cancer risk in the European prospective investigation of cancer and nutrition cohort. Int J Cancer  2015,136(5),1149-1161","journal-title":"Int J Cancer"},{"key":"ref=24","doi-asserted-by":"publisher","first-page":"878","DOI":"10.1016\/j.ijbiomac.2018.05.180","volume":"117","author":"Li Q.","year":"2018","unstructured":"Li Q.; Chen G.; Wang W.; Zhang W.; Ding Y.; Zhao T.; Li F.; Mao G.; Feng W.; Wang Q.; Yang L.; Wu X.; A novel Se-polysaccharide from Se-enriched G. frondosa protects against immunosuppression and low Se status in Se-deficient mice. Int J Biol Macromol  2018,117,878-889","journal-title":"Int J Biol Macromol"},{"key":"ref=25","doi-asserted-by":"publisher","first-page":"359","DOI":"10.18388\/abp.2018_2628","volume":"65","author":"Korbut E.","year":"2018","unstructured":"Korbut E.; Ptak-Belowska A.; Brzozowski T.; Inhibitory effect of selenomethionine on carcinogenesis in the model of human colorectal cancer in vitro and its link to the Wnt\/\u03b2-catenin pathway. Acta Biochim Pol  2018,65(3),359-366","journal-title":"Acta Biochim Pol"},{"key":"ref=26","doi-asserted-by":"publisher","first-page":"111158","DOI":"10.1016\/j.biopha.2020.111158","volume":"134","author":"Xing C.","year":"2021","unstructured":"Xing C.; Sun S.; Yue Z.Q.; Bai F.; Role of lncRNA LUCAT1 in cancer. Biomed Pharmacother  2021,134,111158","journal-title":"Biomed Pharmacother"},{"key":"ref=27","doi-asserted-by":"publisher","first-page":"1533033820945770","DOI":"10.1177\/1533033820945770","volume":"19","author":"Liu Z.","year":"2020","unstructured":"Liu Z.; Gao H.; Peng Q.; Yang Y.; Long noncoding RNA LUCAT1 promotes multiple myeloma cell growth by regulating the TGF-\u03b2 signaling pathway. Technol Cancer Res Treat  2020,19,1533033820945770","journal-title":"Technol Cancer Res Treat"},{"key":"ref=28","doi-asserted-by":"publisher","first-page":"4005","DOI":"10.1210\/jc.2016-1991","volume":"101","author":"Liyanarachchi S.","year":"2016","unstructured":"Liyanarachchi S.; Li W.; Yan P.; Bundschuh R.; Brock P.; Senter L.; Ringel M.D.; de la Chapelle A.; He H.; Genome-wide expression screening discloses long noncoding RNAs involved in thyroid carcinogenesis. J Clin Endocrinol Metab  2016,101(11),4005-4013","journal-title":"J Clin Endocrinol Metab"},{"key":"ref=29","doi-asserted-by":"publisher","first-page":"1311","DOI":"10.2174\/1386207325666220820112111","volume":"26","author":"Li R.","year":"2023","unstructured":"Li R.; Cui X.; Sun W.; Yang Z.; Shen X.; Zhu C.; ASF1B, as an independent prognostic biomarker, correlates with immune infiltrates in hepatocellular carcinoma. Comb Chem High Throughput Screen  2023,26(7),1311-1323","journal-title":"Comb Chem High Throughput Screen"},{"key":"ref=30","doi-asserted-by":"publisher","first-page":"1596","DOI":"10.2174\/1871520623666230413130417","volume":"23","author":"Zheng Z.","year":"2023","unstructured":"Zheng Z.; Yan G.; Xi N.; Xu X.; Zeng Q.; Wu Y.; Zheng Y.; Zhang G.; Wang X.; Triptolide induces apoptosis and autophagy in cutaneous squamous cell carcinoma via Akt\/mTOR pathway. Anticancer Agents Med Chem  2023,23(13),1596-1604","journal-title":"Anticancer Agents Med Chem"},{"key":"ref=31","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/j.jare.2021.10.007","volume":"39","author":"Zhang Y.","year":"2022","unstructured":"Zhang Y.; Zhang H.; Yang Z.; Zhang X.; Miao Q.; Li M.; Zhai T.; Zheng B.; Wen J.; miR-155 down-regulation protects the heart from hypoxic damage by activating fructose metabolism in cardiac fibroblasts. J Adv Res  2022,39,103-117","journal-title":"J Adv Res"},{"key":"ref=32","doi-asserted-by":"publisher","first-page":"1670","DOI":"10.2174\/1871520623666230420081738","volume":"23","author":"Ruan S.","year":"2023","unstructured":"Ruan S.; Gu L.; Wang Y.; Huang X.; Cao H.; Diosgenin glucoside inhibits the progression of osteosarcoma MG-63 by regulating the PI3K\/AKT\/mTOR pathway. Anticancer Agents Med Chem  2023,23(14),1670-1677","journal-title":"Anticancer Agents Med Chem"},{"key":"ref=33","doi-asserted-by":"publisher","first-page":"427","DOI":"10.2174\/0929866530666230314160234","volume":"30","author":"Ren S.","year":"2023","unstructured":"Ren S.; Chen M.; Chen Y.; Ding K.; NRSN2 is a prognostic biomarker in gastric cancer and facilitates the growth and migration of gastric cancer cells. Protein Pept Lett  2023,30(5),427-438","journal-title":"Protein Pept Lett"},{"key":"ref=34","doi-asserted-by":"publisher","first-page":"2516","DOI":"10.1038\/s41388-018-0602-8","volume":"38","author":"Yang Z.","year":"2019","unstructured":"Yang Z.; Qu C.B.; Zhang Y.; Zhang W.F.; Wang D.D.; Gao C.C.; Ma L.; Chen J.S.; Liu K.L.; Zheng B.; Zhang X.H.; Zhang M.L.; Wang X.L.; Wen J.K.; Li W.; Dysregulation of p53-RBM25-mediated circAMOTL1L biogenesis contributes to prostate cancer progression through the circAMOTL1L-miR-193a-5p-Pcdha pathway. Oncogene  2019,38(14),2516-2532","journal-title":"Oncogene"},{"key":"ref=35","doi-asserted-by":"publisher","first-page":"14","DOI":"10.2174\/1567202620666230502115433","volume":"20","author":"Yu K.","year":"2023","unstructured":"Yu K.; Jiang A.; Zhao C.; Zhang D.; Dual specificity phosphatase 3 (DUSP3) knockdown alleviates acute myocardial infarction damage via inhibiting apoptosis and inflammation. Curr Neurovasc Res  2023,20(1),14-22","journal-title":"Curr Neurovasc Res"},{"key":"ref=36","doi-asserted-by":"publisher","first-page":"1793","DOI":"10.2174\/1871520621666210906092314","volume":"22","author":"Saleem M.","year":"2022","unstructured":"Saleem M.; Schini-Kerth V.B.; Hussain K.; Khalid S.H.; Asif M.; Alhosin M.; Akhtar M.F.; Ahmad B.; Raza A.; Mahrukh, Molecular mechanisms responsible for in vitro cytotoxic attributes of conyza bonariensis extract against lymphoblastic leukaemia jurkat cells. Anticancer Agents Med Chem  2022,22(9),1793-1801","journal-title":"Anticancer Agents Med Chem"},{"key":"ref=37","doi-asserted-by":"publisher","first-page":"51","DOI":"10.2174\/2211536610666210412155206","volume":"10","author":"Rattanapan Y.","year":"2021","unstructured":"Rattanapan Y.; Korkiatsakul V.; Kongruang A.; Siriboonpiputtana T.; Rerkamnuaychoke B.; Chareonsirisuthigul T.; High expression of miR-483-5p predicts chemotherapy resistance in epithelial ovarian cancer. MicroRNA  2021,10(1),51-57","journal-title":"MicroRNA"},{"key":"ref=38","doi-asserted-by":"publisher","first-page":"7787","DOI":"10.7150\/thno.46911","volume":"10","author":"Yang G.","year":"2020","unstructured":"Yang G.; Zheng B.; Qin Y.; Zhou J.; Yang Z.; Zhang X.; Zhao H.; Yang H.; Wen J.; Salvia miltiorrhiza -derived miRNAs suppress vascular remodeling through regulating OTUD7B\/KLF4\/NMHC IIA axis. Theranostics  2020,10(17),7787-7811","journal-title":"Theranostics"},{"key":"ref=39","doi-asserted-by":"publisher","first-page":"1749","DOI":"10.2174\/1381612826666200311125325","volume":"26","author":"Khosravi M.","year":"2020","unstructured":"Khosravi M.; Kakavandi N.; Rezaee S.; Shabani M.; Najafi M.; A peptide construct mediates focal adhesion pathway through the activation of integrin receptor. Curr Pharm Des  2020,26(15),1749-1755","journal-title":"Curr Pharm Des"},{"key":"ref=40","doi-asserted-by":"publisher","first-page":"4236","DOI":"10.1093\/nar\/gkv240","volume":"43","author":"Hrossova D.","year":"2015","unstructured":"Hrossova D.; Sikorsky T.; Potesil D.; Bartosovic M.; Pasulka J.; Zdrahal Z.; Stefl R.; Vanacova S.; RBM7 subunit of the NEXT complex binds U-rich sequences and targets 3\u2032-end extended forms of snRNAs. Nucleic Acids Res  2015,43(8),4236-4248","journal-title":"Nucleic Acids Res"},{"key":"ref=41","doi-asserted-by":"publisher","first-page":"1729","DOI":"10.2174\/1386207325666221010112601","volume":"26","author":"Bi Y.","year":"2023","unstructured":"Bi Y.; Jin S.; Tang G.; Pan D.; Song X.; Zhu X.; Tan S.; Prognostic significance of ZP3 in hepatocellular carcinoma. Comb Chem High Throughput Screen  2023,26(9),1729-1736","journal-title":"Comb Chem High Throughput Screen"},{"key":"ref=42","doi-asserted-by":"publisher","first-page":"e22602","DOI":"10.1096\/fj.202200673RRR","volume":"36","author":"Zhao A.N.","year":"2022","unstructured":"Zhao A.N.; Yang Z.; Wang D.D.; Shi B.; Zhang H.; Bai Y.; Yan B.W.; Zhang Y.; Wen J.K.; Wang X.L.; Qu C.B.; Disturbing NLRP3 acetylation and inflammasome assembly inhibits androgen receptor\u2010promoted inflammatory responses and prostate cancer progression. FASEB J  2022,36(11),e22602","journal-title":"FASEB J"},{"key":"ref=43","doi-asserted-by":"publisher","first-page":"327","DOI":"10.3892\/etm.2021.9758","volume":"21","author":"Zhang A.D.","year":"2021","unstructured":"Zhang A.D.; Su X.H.; Wang Y.F.; Shi G.F.; Han C.; Zhang N.; Predicting the effects of radiotherapy based on diffusion kurtosis imaging in a xenograft mouse model of esophageal carcinoma. Exp Ther Med  2021,21(4),327","journal-title":"Exp Ther Med"},{"key":"ref=44","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1186\/s13072-023-00483-w","volume":"16","author":"Zhu M.","year":"2023","unstructured":"Zhu M.; Zhang R.N.; Zhang H.; Qu C.; Zhang X.; Ren L.X.; Yang Z.; Gu J.F.; PCGF6\/MAX\/KDM5D facilitates MAZ\/CDK4 axis expression and pRCC progression by hypomethylation of the DNA promoter. Epigenetics Chromatin  2023,16(1),9","journal-title":"Epigenetics Chromatin"},{"key":"ref=45","doi-asserted-by":"publisher","first-page":"312","DOI":"10.2174\/1568009621666211222154129","volume":"22","author":"Hudson R.","year":"2022","unstructured":"Hudson R.; Yao H.P.; Suthe S.R.; Patel D.; Wang M.H.; Antibody-drug conjugate PCMC1D3-Duocarmycin SA as a novel therapeutic entity for targeted treatment of cancers aberrantly expressing MET receptor tyrosine kinase. Curr Cancer Drug Targets  2022,22(4),312-327","journal-title":"Curr Cancer Drug Targets"},{"key":"ref=46","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1186\/s13045-022-01272-w","volume":"15","author":"Liu Y.","year":"2022","unstructured":"Liu Y.; Shi M.; He X.; Cao Y.; Liu P.; Li F.; Zou S.; Wen C.; Zhan Q.; Xu Z.; Wang J.; Sun B.; Shen B.; LncRNA-PACERR induces pro-tumour macrophages via interacting with miR-671-3p and m6A-reader IGF2BP2 in pancreatic ductal adenocarcinoma. J Hematol Oncol  2022,15(1),52","journal-title":"J Hematol Oncol"},{"key":"ref=47","doi-asserted-by":"publisher","first-page":"4083","DOI":"10.1080\/15548627.2021.1901204","volume":"17","author":"Luo Y.","year":"2021","unstructured":"Luo Y.; Zheng S.; Wu Q.; Wu J.; Zhou R.; Wang C.; Wu Z.; Rong X.; Huang N.; Sun L.; Bin J.; Liao Y.; Shi M.; Liao W.; Long noncoding RNA (lncRNA) EIF3J-DT induces chemoresistance of gastric cancer via autophagy activation. Autophagy  2021,17(12),4083-4101","journal-title":"Autophagy"},{"key":"ref=48","doi-asserted-by":"publisher","first-page":"628","DOI":"10.1161\/CIRCRESAHA.117.311441","volume":"121","author":"Sun Y.","year":"2017","unstructured":"Sun Y.; Yang Z.; Zheng B.; Zhang X.; Zhang M.; Zhao X.; Zhao H.; Suzuki T.; Wen J.; A novel regulatory mechanism of smooth muscle \u03b1-actin expression by NRG-1\/circACTA2\/miR-548f-5p axis. Circ Res  2017,121(6),628-635","journal-title":"Circ Res"},{"key":"ref=49","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1186\/s12943-019-0947-9","volume":"18","author":"Chen J.","year":"2019","unstructured":"Chen J.; Yu Y.; Li H.; Hu Q.; Chen X.; He Y.; Xue C.; Ren F.; Ren Z.; Li J.; Liu L.; Duan Z.; Cui G.; Sun R.; Long non-coding RNA PVT1 promotes tumor progression by regulating the miR-143\/HK2 axis in gallbladder cancer. Mol Cancer  2019,18(1),33","journal-title":"Mol Cancer"},{"key":"ref=50","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1186\/s13578-019-0345-4","volume":"9","author":"Zhang H.","year":"2019","unstructured":"Zhang H.; Wei P.; Lv W.; Han X.; Yang J.; Qin S.; Long noncoding RNA lnc-DILC stabilizes PTEN and suppresses clear cell renal cell carcinoma progression. Cell Biosci  2019,9(1),81","journal-title":"Cell Biosci"},{"key":"ref=51","doi-asserted-by":"publisher","first-page":"13679","DOI":"10.1016\/S0021-9258(18)80050-3","volume":"264","author":"Dong Y.","year":"1989","unstructured":"Dong Y.; Aronsson M.; Gustafsson J.A.; Okret S.; The mechanism of cAMP-induced glucocorticoid receptor expression. Correlation to cellular glucocorticoid response. J Biol Chem  1989,264(23),13679-13683","journal-title":"J Biol Chem"},{"key":"ref=52","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1007\/s12011-013-9696-6","volume":"153","author":"Ying X.","year":"2013","unstructured":"Ying X.; Chen X.; Cheng S.; Zhao Z.; Guo X.; Chen H.; Hong J.; Peng L.; Xu H.; SeMet inhibits IL-1\u03b2-induced rheumatoid fibroblast-like synoviocytes proliferation and the production of inflammatory mediators. Biol Trace Elem Res  2013,153(1-3),437-445","journal-title":"Biol Trace Elem Res"},{"key":"ref=53","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1080\/13510002.2020.1807088","volume":"25","author":"Schmitt A.","year":"2020","unstructured":"Schmitt A.; Br\u00e4ndle A.L.; Herzog P.; R\u00f6chner F.; Fragasso A.; Munz B.; Effects of the anti-oxidant PDTC in combination with a single bout of treadmill running on murine skeletal muscle. Redox Rep  2020,25(1),70-79","journal-title":"Redox Rep"},{"key":"ref=54","doi-asserted-by":"publisher","first-page":"2586","DOI":"10.3748\/wjg.v27.i20.2586","volume":"27","author":"Lei G.L.","year":"2021","unstructured":"Lei G.L.; Niu Y.; Cheng S.J.; Li Y.Y.; Bai Z.F.; Yu L.X.; Hong Z.X.; Liu H.; Liu H.H.; Yan J.; Gao Y.; Zhang S.G.; Chen Z.; Li R.S.; Yang P.H.; Upregulation of long noncoding RNA W42 promotes tumor development by binding with DBN1 in hepatocellular carcinoma. World J Gastroenterol  2021,27(20),2586-2602","journal-title":"World J Gastroenterol"},{"key":"ref=55","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1016\/j.cell.2011.07.014","volume":"146","author":"Salmena L.","year":"2011","unstructured":"Salmena L.; Poliseno L.; Tay Y.; Kats L.; Pandolfi P.P.; A ceRNA hypothesis: The rosetta stone of a hidden RNA language? Cell  2011,146(3),353-358","journal-title":"Cell"},{"key":"ref=56","doi-asserted-by":"publisher","first-page":"2610","DOI":"10.18632\/aging.101933","volume":"11","author":"Wang W.","year":"2019","unstructured":"Wang W.; Lou W.; Ding B.; Yang B.; Lu H.; Kong Q.; Fan W.; A novel mRNA-miRNA-lncRNA competing endogenous RNA triple sub-network associated with prognosis of pancreatic cancer. Aging  2019,11(9),2610-2627","journal-title":"Aging"},{"key":"ref=57","doi-asserted-by":"publisher","first-page":"13487","DOI":"10.1002\/jcb.28622","volume":"120","author":"Luo H.","year":"2019","unstructured":"Luo H.; Xu C.; Le W.; Ge B.; Wang T.; lncRNA CASC11 promotes cancer cell proliferation in bladder cancer through miRNA\u2010150. J Cell Biochem  2019,120(8),13487-13493","journal-title":"J Cell Biochem"},{"key":"ref=58","doi-asserted-by":"publisher","first-page":"1202","DOI":"10.1016\/j.jaci.2017.08.034","volume":"141","author":"Lu T.X.","year":"2018","unstructured":"Lu T.X.; Rothenberg M.E.; MicroRNA. J Allergy Clin Immunol  2018,141(4),1202-1207","journal-title":"J Allergy Clin Immunol"},{"key":"ref=59","doi-asserted-by":"publisher","first-page":"641487","DOI":"10.3389\/fonc.2021.641487","volume":"11","author":"Liu P.","year":"2021","unstructured":"Liu P.; Wei J.; Mao F.; Xin Z.; Duan H.; Du Y.; Wang X.; Li Z.; Qian J.; Yao J.; Establishment of a prognostic model for hepatocellular carcinoma based on endoplasmic reticulum stress-related gene analysis. Front Oncol  2021,11,641487","journal-title":"Front Oncol"},{"key":"ref=60","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1007\/s11033-006-9007-9","volume":"33","author":"Li Q.","year":"2006","unstructured":"Li Q.; Yan W.; Cheng S.; Guo S.; Wang W.; Zhang Z.; Wang L.; Zhang J.; Wang W.; Introduction of G1 phase arrest in Human Hepatocellular carcinoma cells (HHCC) by APMCF1 gene transfection through the down-regulation of TIMP3 and up-regulation of the CDK inhibitors p21. Mol Biol Rep  2006,33(4),257-263","journal-title":"Mol Biol Rep"},{"key":"ref=61","first-page":"161","volume":"60","author":"Cirrottola F.","year":"2003","unstructured":"Cirrottola F.; Scrutinio D.; Role of professional nurses in the management of patients with chronic heart failure in cardiac rehabilitation. Monaldi Arch Chest Dis  2003,60(2),161-165","journal-title":"Monaldi Arch Chest Dis"},{"key":"ref=62","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1186\/s12885-018-4031-4","volume":"18","author":"Song Q.","year":"2018","unstructured":"Song Q.; Chen Q.; Wang Q.; Yang L.; Lv D.; Jin G.; Liu J.; Li B.; Fei X.; ATF-3\/miR-590\/GOLPH3 signaling pathway regulates proliferation of breast cancer. BMC Cancer  2018,18(1),255","journal-title":"BMC Cancer"},{"key":"ref=63","doi-asserted-by":"publisher","first-page":"809590","DOI":"10.3389\/fimmu.2022.809590","volume":"13","author":"Guenther C.","year":"2022","unstructured":"Guenther C.; \u03b22-Integrins \u2013 Regulatory and executive bridges in the signaling network controlling leukocyte trafficking and migration. Front Immunol  2022,13,809590","journal-title":"Front Immunol"},{"key":"ref=64","doi-asserted-by":"publisher","first-page":"e992","DOI":"10.1002\/ctm2.992","volume":"12","author":"Song J.","year":"2022","unstructured":"Song J.; Lin Z.; Liu Q.; Huang S.; Han L.; Fang Y.; Zhong P.; Dou R.; Xiang Z.; Zheng J.; Zhang X.; Wang S.; Xiong B.; MiR\u2010192\u20105p\/RB1\/NF\u2010\u03baBp65 signaling axis promotes IL\u201010 secretion during gastric cancer EMT to induce Treg cell differentiation in the tumour microenvironment. Clin Transl Med  2022,12(8),e992","journal-title":"Clin Transl Med"},{"key":"ref=65","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1007\/s10456-021-09776-8","volume":"24","author":"Lees D.M.","year":"2021","unstructured":"Lees D.M.; Reynolds L.E.; Pedrosa A.R.; Roy-Luzarraga M.; Hodivala-Dilke K.M.; Phosphorylation of pericyte FAK-Y861 affects tumour cell apoptosis and tumour blood vessel regression. Angiogenesis  2021,24(3),471-482","journal-title":"Angiogenesis"},{"key":"ref=66","doi-asserted-by":"publisher","first-page":"882330","DOI":"10.3389\/fcvm.2022.882330","volume":"9","author":"Patil S.","year":"2022","unstructured":"Patil S.; Rojulpote C.; Amanullah A.; Primary aldosteronism and ischemic heart disease. Front Cardiovasc Med  2022,9,882330","journal-title":"Front Cardiovasc Med"},{"key":"ref=67","doi-asserted-by":"publisher","first-page":"687244","DOI":"10.3389\/fendo.2021.687244","volume":"12","author":"Zhang A.","year":"2021","unstructured":"Zhang A.; Wang X.; Fan C.; Mao X.; The role of Ki67 in evaluating neoadjuvant endocrine therapy of hormone receptor-positive breast cancer. Front Endocrinol  2021,12,687244","journal-title":"Front Endocrinol"},{"key":"ref=68","doi-asserted-by":"publisher","first-page":"35561","DOI":"10.1038\/srep35561","volume":"6","author":"Ohayon D.","year":"2016","unstructured":"Ohayon D.; De Chiara A.; Chapuis N.; Candalh C.; Mocek J.; Ribeil J.A.; Haddaoui L.; Ifrah N.; Hermine O.; Bouillaud F.; Frachet P.; Bouscary D.; Witko-Sarsat V.; Cytoplasmic proliferating cell nuclear antigen connects glycolysis and cell survival in acute myeloid leukemia. Sci Rep  2016,6(1),35561","journal-title":"Sci Rep"},{"key":"ref=69","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1038\/s41416-022-02047-3","volume":"128","author":"Kock am Brink M.","year":"2023","unstructured":"Kock am Brink M.; Dunst L.S.; Behrens H.M.; Kr\u00fcger S.; Becker T.; R\u00f6cken C.; Intratumoral heterogeneity affects tumor regression and Ki67 proliferation index in perioperatively treated gastric carcinoma. Br J Cancer  2023,128(2),375-386","journal-title":"Br J Cancer"},{"key":"ref=70","doi-asserted-by":"publisher","first-page":"1528","DOI":"10.1093\/jn\/136.6.1528","volume":"136","author":"Zeng H.","year":"2006","unstructured":"Zeng H.; Briske-Anderson M.; Idso J.P.; Hunt C.D.; The selenium metabolite methylselenol inhibits the migration and invasion potential of HT1080 tumor cells. J Nutr  2006,136(6),1528-1532","journal-title":"J Nutr"},{"key":"ref=71","first-page":"557","volume":"20","author":"Kim A.","year":"2008","unstructured":"Kim A.; Jung J.Y.; Son M.; Lee S.H.; Lim J.S.; Chung A.S.; Long exposure of non-cytotoxic concentrations of methylselenol suppresses the invasive potential of B16F10 melanoma. Oncol Rep  2008,20(3),557-565","journal-title":"Oncol Rep"},{"key":"ref=72","doi-asserted-by":"publisher","first-page":"2690","DOI":"10.1111\/febs.13527","volume":"283","author":"Zheng J.H.","year":"2016","unstructured":"Zheng J.H.; Viacava Follis A.; Kriwacki R.W.; Moldoveanu T.; Discoveries and controversies in BCL \u20102 protein\u2010mediated apoptosis. FEBS J  2016,283(14),2690-2700","journal-title":"FEBS J"},{"key":"ref=73","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/S0304-3835(97)00497-7","volume":"125","author":"Redman C.","year":"1998","unstructured":"Redman C.; Scott J.A.; Baines A.T.; Basye J.L.; Clark L.C.; Calley C.; Roe D.; Payne C.M.; Nelson M.A.; Inhibitory effect of selenomethionine on the growth of three selected human tumor cell lines. Cancer Lett  1998,125(1-2),103-110","journal-title":"Cancer Lett"},{"key":"ref=74","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3727\/096504009789745647","volume":"18","author":"Yang Y.","year":"2009","unstructured":"Yang Y.; Huang F.; Ren Y.; Xing L.; Wu Y.; Li Z.; Pan H.; Xu C.; The anticancer effects of sodium selenite and selenomethionine on human colorectal carcinoma cell lines in nude mice. Oncol Res  2009,18(1),1-8","journal-title":"Oncol Res"},{"key":"ref=75","doi-asserted-by":"publisher","first-page":"5981","DOI":"10.21873\/anticanres.11186","volume":"36","author":"Dai X.","year":"2016","unstructured":"Dai X.; Thongchot S.; Dokduang H.; Loilome W.; Khuntikeo N.; Titapun A.; Ungarreevittaya P.; Yongvanit P.; Techasen A.; Namwat N.; Potential of selenium compounds as new anticancer agents for cholangiocarcinoma. Anticancer Res  2016,36(11),5981-5988","journal-title":"Anticancer Res"}],"container-title":["Combinatorial Chemistry &amp; High Throughput Screening"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/0113862073286006231228070738","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/225109\/article","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/0113862073286006231228070738","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,3]],"date-time":"2024-10-03T06:27:46Z","timestamp":1727936866000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.eurekaselect.com\/225109\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10]]},"references-count":75,"journal-issue":{"issue":"16","published-print":{"date-parts":[[2024,10]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/0113862073286006231228070738","relation":{},"ISSN":["1386-2073"],"issn-type":[{"value":"1386-2073","type":"print"}],"subject":[],"published":{"date-parts":[[2024,10]]},"assertion":[{"value":"Peer Reviewed","order":0,"name":"review_status","label":"Review Status","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Single blind","order":1,"name":"review_process","label":"Review Process","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Checked with iThenticate","order":0,"name":"screening_status","label":"Screening Status","group":{"name":"plagiarism_screening","label":"Plagiarism Screening"}},{"value":"2023-10-24","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-12-11","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-12-23","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-07-23","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}